Track ENDRA Life Sciences's long-term debt ($330K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), NDRA shows a long-term debt of $330K. That compares with $460K in the prior-year period — down 29.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NDRA's long-term debt is now $330K (was $460K) — a 29.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether ENDRA Life Sciences is outperforming or lagging.
Tracking NDRA's long-term debt over time shows whether ENDRA Life Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $330K That compares with $460K in the prior-year period — down 29.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has ENDRA Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $330K) with ownership activity and broader fundamentals.
ENDRA Life Sciences's long-term debt is $330K; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.